Roivant Sciences Ltd. Common Shares vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.21 (market cap $4.35B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 5.7× State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF for 40 Days on average.
| ROIV | SJNK | |
|---|---|---|
Market Cap | $24.72B | $4.35B |
Volume | 6,279,442 | 3,211,044 |
Sector | Health | Fixed Income |
52-Week High | $41.81 | $25.57 |
52-Week Low | $16.04 | $24.13 |
Typical Hold Time | 0 Days | 40 Days |
Enterprise Value | $20.99B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SJNK (SPDR Bloomberg Short Term High Yield Bond ETF) trades at $24.20, down 0.21% with a bearish technical outlook. The ETF shows strong institutional interest despite recent selling activity by some firms. Dividend distributions remain consistent with recent payments of $0.14-$0.15 per share, providing income appeal in a rising rate environment.
The ETF faces headwinds from technical weakness but maintains income appeal through consistent dividends. Key risks include interest rate sensitivity and institutional selling pressure, while the current yield advantage over Treasuries presents opportunity for income-focused investors in the high-yield bond space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →